Hydrogen sulfide donors in research and drug development

被引:94
作者
Song, Zhi Jian [1 ]
Mei Ying Ng [4 ]
Lee, Zheng-Wei [4 ]
Dai, Weilu [2 ]
Hagen, Thilo [4 ]
Moore, Philip K. [3 ]
Huang, Dejian [2 ]
Deng, Lih-Wen [4 ]
Tan, Choon-Hong [1 ]
机构
[1] Nanyang Technol Univ, Sch Phys & Math Sci, Div Chem & Biol Chem, Singapore 639798, Singapore
[2] Natl Univ Singapore, Dept Chem, Singapore 117548, Singapore
[3] Natl Univ Singapore, Dept Pharmacol, Singapore 117548, Singapore
[4] Natl Univ Singapore, Dept Biochem, Singapore 117548, Singapore
关键词
NF-KAPPA-B; LIPOPOLYSACCHARIDE-INDUCED INFLAMMATION; EFFECTS IN-VITRO; NITRIC-OXIDE; CANCER-CELLS; LEUKOCYTE TRAFFICKING; ANTITUMOR-ACTIVITY; PROTEIN-KINASES; NOSH-ASPIRIN; SUBSTANCE-P;
D O I
10.1039/c3md00362k
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hydrogen sulfide (H2S) has recently emerged as an important biological gasomediator as a result of numerous insightful studies. The use of H2S releasing compounds has attracted much attention as they can exert crucial effects on a wide range of cellular signaling processes. Some of these effects are potentially exploitable in terms of anti-inflammatory and anti-tumor effects, as well as precise ion-channel regulation, cardiovascular protection and oxidation resistance. Unfortunately, the potential therapeutic effects of H2S are controversial due to conflicting published results regarding its effects on cellular activities arising, perhaps in part, from the use of different H2S donors. Therefore it is essential to review the most commonly used H2S releasing compounds, some of which are currently in clinical trials along with their associated in vitro and/or in vivo biological effects.
引用
收藏
页码:557 / 570
页数:14
相关论文
共 142 条
[1]   AGED GARLIC EXTRACT WITH SUPPLEMENT SLOWED THE PROGRESSION OF METABOLICALLY ACTIVE EPICARDIAL ADIPOSE TISSUE, INFLAMMATION AND CORONARY ATHEROSCLEROSIS: A RANDOMIZED CLINICAL TRIAL [J].
Ahmadi, Naser ;
Larijani, Vahid Nabavi ;
Hajsadeghi, Fereshteh ;
Baskett, Michael ;
Flores, Ferdinand ;
Ebrahimi, Ramin ;
Tsimikas, Sotirios ;
Budoff, Matthew .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 59 (13) :E1347-E1347
[2]   THE ANTIOXIDANT ACTION OF ERGOTHIONEINE [J].
AKANMU, D ;
CECCHINI, R ;
ARUOMA, OI ;
HALLIWELL, B .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1991, 288 (01) :10-16
[3]   Novel imidazo[2,1-b][1,3,4]thiadiazole carrying rhodanine-3-acetic acid as potential antitubercular agents [J].
Alegaon, Shankar G. ;
Alagawadi, Kallanagouda R. ;
Sonkusare, Pranali V. ;
Chaudhary, Sagar M. ;
Dadwe, Dilip H. ;
Shah, Amol S. .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (05) :1917-1921
[4]  
Amagase H, 2001, J NUTR, V131, p955S, DOI 10.1093/jn/131.3.955S
[5]   Leukocyte trafficking and pain behavioral responses to a hydrogen sulfide donor in acute monoarthritis [J].
Andruski, Benjamin ;
McCafferty, Donna-Marie ;
Ignacy, Teegan ;
Millen, Brandie ;
McDougall, Jason J. .
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2008, 295 (03) :R814-R820
[6]   Ovothiol and trypanothione as antioxidants in trypanosomatids [J].
Ariyanayagam, MR ;
Fairlamb, AH .
MOLECULAR AND BIOCHEMICAL PARASITOLOGY, 2001, 115 (02) :189-198
[7]   Protection against oxidative damage and cell death by the natural antioxidant ergothioneine [J].
Aruoma, OI ;
Spencer, JPE ;
Mahmood, N .
FOOD AND CHEMICAL TOXICOLOGY, 1999, 37 (11) :1043-1053
[8]   1,2-Dithiolan-3-one 1-oxides: A class of thiol-activated DNA-Cleaving agents that are structurally related to the natural product leinamycin [J].
Behroozi, SJ ;
Kim, W ;
Dannaldson, J ;
Gates, KS .
BIOCHEMISTRY, 1996, 35 (06) :1768-1774
[9]  
Beppu H., 2010, INT J ANAL BIOSCI, V33, P441
[10]  
Bhatia M., 2012, SCI CAIRO, V2012, P1, DOI DOI 10.6064/2012/159680.2012